Understand it is a different disease however mortality is quite similar to severe Covid-19 ARDS (60%+), sitting at 70%+ for pediatric SR-GvHD. Also mortalities associated with Covid-19 ARDS seem to occur in a much shorter time frame (days-weeks) compared to pediatric SR-GvHD (weeks-months). So I think looking at the longer 100 day survival rate for pediatric SR-GvHD provides a fairer comparison (30 day survival was close to 95% in the trials).
Personally I'd be interested in the results but understand if you don't want to go through all that effort again.
Understand it is a different disease however mortality is quite...
-
- There are more pages in this discussion • 203 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.015(1.29%) |
Mkt cap ! $1.347B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $4.551M | 3.886M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 98246 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 19079 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |